Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Joëlle Collignon"'
Autor:
Concetta Elisa Onesti, Hélène Schroeder, Andrée Rorive, Brieuc Sautois, Marie Lecocq, Marie Goffin, Elodie Gonne, Astrid Collinge, Laurence Nicolaers, Odile Wéra, Amandine Catot, Catherine Loly, Astrid Paulus, Anne Sibille, Laurence Lousberg, Florence Troisfontaine, Joëlle Collignon, Christine Gennigens, Pierre Frères, Marc Polus, Bernard Duysinx, Frédérique Vaillant, Nathalie Marchal, Aurélie Poncin, Guy Jerusalem
Publikováno v:
Cancer Reports, Vol 5, Iss 10, Pp n/a-n/a (2022)
Abstract Background The spread of the COVID‐19 pandemic has led to a rapid reorganization in all human and hospital activities, with impact on cancer patients. Aim An analysis of cancer patients fears, and awareness of COVID‐19 has been done in t
Externí odkaz:
https://doaj.org/article/4801fa676c274876a0c7ba8b5957c880
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 8 (2016)
In this article, we focus on the subtype of estrogen receptor (ER)-positive, human epidermal growth factor 2 (HER2)-positive breast cancer (BC). Preclinical and clinical data indicate a complex molecular bidirectional crosstalk between the ER and HER
Externí odkaz:
https://doaj.org/article/0f5791025ae84d15abbf8d49907ba8bc
Autor:
Guy Jerusalem, Nor Eddine Sounni, Agnès Noël, Elisabetta Marangoni, Véronique Jossa, Michel Coibion, Joëlle Collignon, Sophie Château-Joubert, Elodie Montaudon, Erik Maquoi, Laetitia Montero-Ruiz, Mehdi Lienard, Silvia Blacher, Jean Radermacher, Cassandre Yip, Pierre Foidart
Supplemental data include a Supplemental Table-1, Supplemental Figure 1, Supplemental Figure 2, Supplemental Figure 3, Supplemental Figure 4, Supplemental Figure 5 and Supplemental Figure 6. Supplemental Table-1 is related to Figure 1 Supplemental Fi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ee9372e722db3dd3ed1ee1ef5b948a2
https://doi.org/10.1158/1078-0432.22472927
https://doi.org/10.1158/1078-0432.22472927
Autor:
Guy Jerusalem, Nor Eddine Sounni, Agnès Noël, Elisabetta Marangoni, Véronique Jossa, Michel Coibion, Joëlle Collignon, Sophie Château-Joubert, Elodie Montaudon, Erik Maquoi, Laetitia Montero-Ruiz, Mehdi Lienard, Silvia Blacher, Jean Radermacher, Cassandre Yip, Pierre Foidart
Purpose:Here, we investigated the clinical relevance of an unprecedented combination of three biomarkers in triple-negative breast cancer (TNBC), both in human samples and in patient-derived xenografts of TNBC (PDX-TNBC): EGFR, its recently identifie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::047c1d729f1da9d2c61a5fe29589abde
https://doi.org/10.1158/1078-0432.c.6528377
https://doi.org/10.1158/1078-0432.c.6528377
Autor:
Maria Valeria Freire, Marie Martin, Karin Segers, Edith Sepulchre, Natacha Leroi, Hassan Kalantari, Pascal Wolter, Joëlle Collignon, Marc Polus, Olivier Plomteux, Claire Josse, Vincent Bours
Purpose. Pathogenic variants (PVs) in BRCA2 and ATMgenes have been linked to an increased risk of various cancers. BRCA2and ATM are part of the homologous recombination pathway, but the tumor risk in patients with simultaneous PVs in both genes remai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::458ace06afe3db5596fbb9a956f14dfe
https://doi.org/10.21203/rs.3.rs-2112256/v1
https://doi.org/10.21203/rs.3.rs-2112256/v1
Publikováno v:
Current Opinion in Gastroenterology. 36:48-54
Purpose of review To synthesize the current knowledge and guidelines on the management of appendiceal neuroendocrine neoplasms (ANENs). Recent findings Most recent guidelines are essentially based on heterogeneous retrospective series. With the adven
Autor:
Concetta Elisa, Onesti, Hélène, Schroeder, Andrée, Rorive, Brieuc, Sautois, Marie, Lecocq, Marie, Goffin, Elodie, Gonne, Astrid, Collinge, Laurence, Nicolaers, Odile, Wéra, Amandine, Catot, Catherine, Loly, Astrid, Paulus, Anne, Sibille, Laurence, Lousberg, Florence, Troisfontaine, Joëlle, Collignon, Christine, Gennigens, Pierre, Frères, Marc, Polus, Bernard, Duysinx, Frédérique, Vaillant, Nathalie, Marchal, Aurélie, Poncin, Guy, Jerusalem
Publikováno v:
Cancer Reports
Background The spread of the COVID‐19 pandemic has led to a rapid reorganization in all human and hospital activities, with impact on cancer patients. Aim An analysis of cancer patients fears, and awareness of COVID‐19 has been done in this study
Autor:
Richard Greil, Christiane Jungels, Luis Paz-Ares, E. Van Cutsem, Lars Thorsson, L. Østergaard Poulsen, Sebastian Ochsenreither, S. Cicenas, Dirk Arnold, J. Yachnin, M. Zematis, Joëlle Collignon, R.L. Eefsen, I. Garcia Ribas, Ahmad Awada, Per Pfeiffer
Publikováno v:
Annals of Oncology. 32:S602-S603
Autor:
Chloé Wyndham-Thomas, Vincent Colombie, Anke Vanhoenacker, Sylvie Rottey, Rémy Demeester, Nina Van Goethem, Kristof Bafort, Dominique Van Beckhoven, Thierry Dugernier, Roeland Verstraete, Quentin Delefortrie, Hans Wildiers, Elise Willems, Joëlle Collignon, Leila Belkhir, Mélanie Delvallee, Jean-Charles Goeminne, Séverine Noirhomme, Filip Triest, Annouschka Laenen, Erica Sermijn, Kevin Punie, Peter Vuylsteke, Jens Van Praet, Frank Staelens, Christine Daubresse, Tatjana Geukens, Catherine Nachtergal, Camelia Rossi, Xavier Holemans, Philippe Minette, Willem Lybaert, Saphia Mokrane, Nathalie Bossuyt, Christel Fontaine, Sandrine Aspeslagh, Carole Schirvel, Jolanda Verheezen, Annemie Rutten, Didier Delmarcelle, Ingrid Louviaux, Mariana Brandão, Wim Demey, Jessika Deblonde, Evandro de Azambuja, PierreYves Machurot, Paul De Munter, Denis Pierard, Nicolas Dauby
Publikováno v:
ESMO Open, Vol 5, Iss 5 (2020)
ESMO OPEN
ESMO Open, 5 (5
ESMO Open
ESMO open, Vol. 5, no. 5, p. e000947 [1-11] (2020)
ESMO OPEN
ESMO Open, 5 (5
ESMO Open
ESMO open, Vol. 5, no. 5, p. e000947 [1-11] (2020)
BACKGROUND: Cancer seems to have an independent adverse prognostic effect on COVID-19-related mortality, but uncertainty exists regarding its effect across different patient subgroups. We report a population-based analysis of patients hospitalised wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83982014b7437747099932e092babdc0
https://hdl.handle.net/20.500.14017/379ab02e-3b70-4a6c-b9d7-477d5870af33
https://hdl.handle.net/20.500.14017/379ab02e-3b70-4a6c-b9d7-477d5870af33
Autor:
Nathalie Marchal, Marie Goffin, Marie Lecocq, Amandine Catot, Concetta Elisa Onesti, Elodie Gonne, Odile Wera, Laurence Nicolaers, Aurélie Poncin, Joëlle Collignon, Andrée Rorive, Christine Gennigens, Bernard Duysinx, Guy Jerusalem, Hélène Schroeder, Pierre Frères, F Vaillant, Marc Polus, Brieuc Sautois, Astrid Collinge
Publikováno v:
Annals of Oncology
Background: No specific safety data concerning systemic oncological treatments were available at time of COVID-19 outbreak in Belgium. In our hospital we decided to maintain adjuvant and early line treatments for metastatic disease in patients under